Foundation Medicine - Crunchbase Company Profile & Funding

Q: Who invested in Foundation Medicine?

Foundation Medicine has 10 investors including Evan Jones And Bill Gates.

Q: How much funding has Foundation Medicine raised to date?

Foundation Medicine has raised obfuscated.

Overview

Foundation Medicine

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+4 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Foundation Medicine

CB Rank

72419

Foundation medicine is a molecular information company developing clinical diagnostic tests that facilitates personalized cancer therapies.

Acquired by

Roche

Founded

obfuscation

Public

Series B

Cambridge, Massachusetts, United States

251-500

www.foundationmedicine.com

Biotechnology

Genetics

Health Care

Medical

Funding Rounds

Series B

OBF

obfuscation

Series B

OBF

obfuscation

Series A

OBF

obfuscation

Key People

Mustafa Abdulali: Director of Operational Excellence
Past Role: NCH Healthcare System, Director of Lean Transformation
Jeffrey Ross: Medical Director, Interim Head of Pathology & Molecular Diagnostics
Past Role: Millennium Pharmaceuticals, Scientific Fellow / Head, Molecular Pathology

Details

Sub-Organization of

Roche

Legal Name

Foundation Medicine, Inc.

Operating Status

Active

Number of Exits

obfuscation

Stock Symbol

NASDAQ:FMI

Company Type

For Profit

Founders

Alexis Borisy

About the Company

Foundation Medicine plans to create clinical diagnostic tests that can use the latest in genetic sequencing technology to identify personalized cancer therapies for patients.

Phone Number

6174182290

Contact Email

info@foundationmedicine.com

Predictions & Insights

Growth Insight

See this Growth Insight

Foundation Medicine is

Lorem

to be growing

Top Contributing Factors

Operations Expansion

Products & Services

FoundationOne®CDx

A tissue-based next-generation sequencing diagnostic test analyzing 324 genes and genomic signatures to identify genomic alterations in advanced solid tumors for treatment guidance.

FoundationOne®Liquid CDx

A blood-based next-generation sequencing diagnostic test analyzing 324 genes from circulating cell-free DNA to detect genomic alterations in advanced solid tumors for treatment decisions.

Research & Development

Foundation Medicine is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Foundation Medicine	2	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Foundation Medicine	2	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Foundation Medicine	2	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Foundation Medicine	2	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Foundation Medicine	2	obfuscated obfuscation	—	Series B

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Foundation Medicine	2	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Foundation Medicine	2	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Foundation Medicine	2	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Foundation Medicine	2	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Foundation Medicine	2	obfuscated obfuscation	—	Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Evan Jones	—	Series B - Foundation Medicine	—
Evan Jones	—	Series B - Foundation Medicine	—
Evan Jones	—	Series B - Foundation Medicine	—
Evan Jones	—	Series B - Foundation Medicine	—
Evan Jones	—	Series B - Foundation Medicine	—

Investments

Investment Breakdown

Number of Investments

Number of Exits

obfuscation

Number of Acquisitions

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Moffitt Cancer Center	Yes	Grant - Moffitt Cancer Center	obfuscated obfuscation
obfuscated obfuscation	Moffitt Cancer Center	Yes	Grant - Moffitt Cancer Center	obfuscated obfuscation
obfuscated obfuscation	Moffitt Cancer Center	Yes	Grant - Moffitt Cancer Center	obfuscated obfuscation
obfuscated obfuscation	Moffitt Cancer Center	Yes	Grant - Moffitt Cancer Center	obfuscated obfuscation
obfuscated obfuscation	Moffitt Cancer Center	Yes	Grant - Moffitt Cancer Center	obfuscated obfuscation

Investment Breakdown

Number of Investments

Number of Exits

obfuscation

Number of Acquisitions

See investment data for this company, with details on deal size, industry, stage, and more.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Moffitt Cancer Center	Yes	Grant - Moffitt Cancer Center	obfuscated obfuscation
obfuscated obfuscation	Moffitt Cancer Center	Yes	Grant - Moffitt Cancer Center	obfuscated obfuscation
obfuscated obfuscation	Moffitt Cancer Center	Yes	Grant - Moffitt Cancer Center	obfuscated obfuscation
obfuscated obfuscation	Moffitt Cancer Center	Yes	Grant - Moffitt Cancer Center	obfuscated obfuscation
obfuscated obfuscation	Moffitt Cancer Center	Yes	Grant - Moffitt Cancer Center	obfuscated obfuscation

M&A Details

Foundation Medicine

was acquired by

Roche

for

obfuscation

. This deal was done in

Cash & Stock

Transaction Name

Foundation Medicine acquired by Roche

Acquired by

Roche

Announced Date

obfuscation

Price

obfuscation

Market Intelligence

People

View Profiles & Contacts

Headcount

251-500

Employee Profiles

Board Members and Advisors

Contacts

1,726

Employee Profiles

Mustafa Abdulali Director of Operational Excellence
Jeffrey Ross Medical Director, Interim Head of Pathology & Molecular Diagnostics
Lincoln Pasquina Associate Director, SmartTrials
Daniel Malarek Chief Executive Officer